Cargando…

The NeuroAiD Safe Treatment (NeST) Registry: a protocol

INTRODUCTION: NeuroAiD (MLC601, MLC901), a combination of natural products, has been shown to be safe and to aid neurological recovery after brain injuries. The NeuroAiD Safe Treatment (NeST) Registry aims to assess its use and safety in the real-world setting. METHODS AND ANALYSIS: The NeST Registr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venketasubramanian, Narayanaswamy, Kumar, Ramesh, Soertidewi, Lyna, Abu Bakar, Azizi, Laik, Carine, Gan, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654343/ https://www.ncbi.nlm.nih.gov/pubmed/26567259 http://dx.doi.org/10.1136/bmjopen-2015-009866

Ejemplares similares

Safety and Use of MLC601/MLC901 (NeuroAiD(TM)) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry
por: Kumar, Ramesh, et al.
Publicado: (2020)

Ischemic Stroke and Savings in Time to Achieve Functional Recovery: Experience from NeuroAiD
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2023)

The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015)

The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
por: Navarro, Jose C., et al.
Publicado: (2012)

Spinal Cord Injury—Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury
por: Kumar, Ramesh, et al.
Publicado: (2016)

Contribution of CNS cells in NeuroAIDS
por: Verma, Ashish Swarup, et al.
Publicado: (2010)

Opiate Drug Use and the Pathophysiology of NeuroAIDS
por: Hauser, Kurt F, et al.
Publicado: (2012)

Role of Biosensing Technology for NeuroAIDS Management
por: Jayant, RD, et al.
Publicado: (2016)

Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
por: Jayant, Rahul Dev, et al.
Publicado: (2018)

Clinical Outcomes of MLC601 (NeuroAiD(TM)) in Traumatic Brain Injury: A Pilot Study
por: Al Fauzi, Asra, et al.
Publicado: (2020)

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
por: Chen, Christopher L.H., et al.
Publicado: (2019)

Spinal cord injury – assessing tolerability and use of combined rehabilitation and NeuroAiD (SATURN) study – primary results of an exploratory study
por: Kumar, Ramesh, et al.
Publicado: (2022)

Molecular epigenetics, chromatin, and NeuroAIDS/HIV: Translational implications
por: Shapshak, Paul, et al.
Publicado: (2008)

Molecular epigenetics, chromatin, and NeuroAIDS/HIV: Immunopathological implications
por: Chiappelli, Francesco, et al.
Publicado: (2008)

NIMH funding opportunities for NeuroAIDS therapeutics development research
por: Bao, Jing, et al.
Publicado: (2006)

Sustained-release nanoART formulation for the treatment of neuroAIDS
por: Jayant, Rahul Dev, et al.
Publicado: (2015)

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
por: Sarma, Anupam, et al.
Publicado: (2020)

MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial
por: Theadom, A., et al.
Publicado: (2018)

Advancing research in NeuroAIDS using collaboration and public data sharing
por: Cysique, Lucette A.
Publicado: (2015)

When do models of NeuroAIDS faithfully imitate “the real thing”?
por: Gelman, Benjamin B., et al.
Publicado: (2017)

HIV-Tat regulates macrophage gene expression in the context of neuroAIDS
por: Carvallo, Loreto, et al.
Publicado: (2017)

Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
por: Hu, Guoku, et al.
Publicado: (2017)

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
por: Moretti, Sonia, et al.
Publicado: (2021)

The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research
por: Heithoff, Abigail J, et al.
Publicado: (2019)

Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
por: Campbell, Jennifer H., et al.
Publicado: (2011)

Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse
por: Sagar, Vidya, et al.
Publicado: (2016)

Systematic Review and Meta-Analysis of the Efficacy of MLC901 (NeuroAiD II(TM)) for Acute Ischemic Brain Injury in Animal Models
por: Ranuh, I. G. M. Aswin R., et al.
Publicado: (2021)

A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques
por: Matsuda, Kenta, et al.
Publicado: (2017)

Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS
por: Sagar, Vidya, et al.
Publicado: (2017)

NeST: nested hierarchical structure identification in spatial transcriptomic data
por: Walker, Benjamin L., et al.
Publicado: (2023)

Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24–25, 2008
por: Joseph, Jeymohan, et al.
Publicado: (2009)

The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies
por: Cserhati, Matyas F., et al.
Publicado: (2015)

Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS
por: Dahal, Santosh, et al.
Publicado: (2015)

HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS
por: Berman, Joan W., et al.
Publicado: (2016)

Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS
por: González, R. Gilberto, et al.
Publicado: (2018)

NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo‐controlled randomized trial
por: Chen, Christopher L. H., et al.
Publicado: (2021)

Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats
por: Repunte-Canonigo, Vez, et al.
Publicado: (2014)

Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS
por: Khan, Saif Ahmad, et al.
Publicado: (2020)

A prospective longitudinal in vivo (1)H MR spectroscopy study of the SIV/macaque model of neuroAIDS
por: Fuller, Robert A, et al.
Publicado: (2004)

The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment
por: Gelman, Benjamin B., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ei9gkvda21h1kco3uekqrq4b8h